Advertisement

Topics

Heron Therapeutics Announces Inclusion of SUSTOL® (Granisetron) Extended-Release Injection in NCCN® Antiemesis Guidelines

08:00 EST 24 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
- SUSTOL Granted Category 1 Recommendation for Use in Patients Receiving Highly or Moderately Emetogenic Chemotherapy (HEC or MEC) - Identified as a “Preferred” Agent for Preventing CINV Following MEC Heron Ther...

Other Sources for this Article

Heron Therapeutics, Inc.
Investor Relations and Media Contact:
David Szekeres, 858-251-4447
Senior VP, General Counsel, Business Development and Corporate Secretary
dszekeres@herontx.com

NEXT ARTICLE

More From BioPortfolio on "Heron Therapeutics Announces Inclusion of SUSTOL® (Granisetron) Extended-Release Injection in NCCN® Antiemesis Guidelines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...